SONLICROMANOL, A KHONRION DRUG UNDER DEV:T FOR MITOCHONDRIAL DISEASE PROPOSED AS A TREATMENT FOR PATIENTS WITH SEVERE COVID:
Khondrion highlights potential role of inflammatory lipid modulator prostaglandin E 2 in COVID-19 disease and proposes potential treatment pathway with sonlicromanol Elevated levels of PGE 2 known to play an essential role in inflammation Inhibition of key enzyme involved in PGE 2 production may offer a potential new treatment […]
Click here to view original web page at www.globenewswire.com